Search research articles
Contact Us
Filters
Showing results (251-260 of 311) with videos related to
Page
of 32
Sort By:
Schizophrenia Bulletin Open
|
July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis
Stefania Tognin, Anja Richter, Matthew J Kempton, et al.
Schizophrenia Bulletin
|
December 23, 2025
Gray Matter Volume Abnormalities and the Association with the Trajectory of Symptoms and Functioning in Individuals at Clinical High Risk of Psychosis
Shuqing Si, Cheryl See, Emily P Hedges, et al.
Schizophrenia Research
|
December 19, 2018
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial
Luke K Bolt, G Paul Amminger, John Farhall, et al.
Early Intervention in Psychiatry
|
September 7, 2020
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis
Alison McLaverty, Kelly A Allott, Maximus Berger, et al.
Psychological Medicine
|
January 8, 2025
The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk study
Cheryl R Z See, Shuqing Si, Emily Hedges, et al.
Psychological Medicine
|
March 12, 2025
Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approach
Isabelle Scott, Emmeke Aarts, Cassandra Wannan, et al.
Schizophrenia Bulletin
|
September 6, 2024
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
Paul Møller, Barnaby Nelson, Patrick D McGorry, et al.
Asian Journal of Psychiatry
|
October 11, 2024
Service users perspectives on psychosis-risk terminology: An Italian study on labeling terms preferences and stigma
Tommaso Boldrini, Gabriele Lo Buglio, Arianna Schiano Lomoriello, et al.
Bjpsych Open
|
September 8, 2022
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
Nicholas Cheng, Alison McLaverty, Barnaby Nelson, et al.
Brain, Behavior, and Immunity
|
October 8, 2021
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
Subash Raj Susai, David Mongan, Colm Healy, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 311) with videos related to
Sort By:
Page
of 32
Schizophrenia Bulletin Open
|
July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis
Stefania Tognin, Anja Richter, Matthew J Kempton, et al.
Schizophrenia Bulletin
|
December 23, 2025
Gray Matter Volume Abnormalities and the Association with the Trajectory of Symptoms and Functioning in Individuals at Clinical High Risk of Psychosis
Shuqing Si, Cheryl See, Emily P Hedges, et al.
Schizophrenia Research
|
December 19, 2018
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial
Luke K Bolt, G Paul Amminger, John Farhall, et al.
Early Intervention in Psychiatry
|
September 7, 2020
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis
Alison McLaverty, Kelly A Allott, Maximus Berger, et al.
Psychological Medicine
|
January 8, 2025
The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk study
Cheryl R Z See, Shuqing Si, Emily Hedges, et al.
Psychological Medicine
|
March 12, 2025
Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approach
Isabelle Scott, Emmeke Aarts, Cassandra Wannan, et al.
Schizophrenia Bulletin
|
September 6, 2024
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
Paul Møller, Barnaby Nelson, Patrick D McGorry, et al.
Asian Journal of Psychiatry
|
October 11, 2024
Service users perspectives on psychosis-risk terminology: An Italian study on labeling terms preferences and stigma
Tommaso Boldrini, Gabriele Lo Buglio, Arianna Schiano Lomoriello, et al.
Bjpsych Open
|
September 8, 2022
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
Nicholas Cheng, Alison McLaverty, Barnaby Nelson, et al.
Brain, Behavior, and Immunity
|
October 8, 2021
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
Subash Raj Susai, David Mongan, Colm Healy, et al.
Page
of 32